BeStock  
Stocks › Biotechnology › PGEN

Precigen PGEN

US equityMarket cap rank #2871Biotechnology
$4.21 +$0.05 (+1.20%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.24 +0.61%
Open$4.16
Prev close$4.16
Day range$4.07 – $4.36
Volume6.07M
Market cap$1.51B
P/E (TTM)38.3
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership74.8%+0.44 pts vs. prior quarter
Institutions holding271+21 vs. prior quarter
Insider trades (recent)25 buys / 25 sellsBalanced
Short interest12.54% of floatDays to cover 8.6 · as of 30 Oct 2026
Short-sale volume share21.4%5-day average of daily volume

Short-sale volume as % of daily volume

8%15%21%27%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$2.65M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

+$2.3MSuper+$371.5KBig+$4.6MMid+$6.8MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 48.6% of shares outstanding.

Largest holders

  • Third Security, LLC29.02%
  • Patient Capital Management, LLC5.01%
  • E. Merck KG4.87%
  • William Miller4.85%
  • BlackRock4.82%
  • Randal Kirk3.74%
  • State Street Global Advisors2.99%
  • Diametric Capital, LP2.59%

By investor type

  • Mutual Fund29.08%
  • VC/PE Fund29.02%
  • Individual/Insider11.69%
  • Hedge Fund7.30%
  • Private Company5.90%
  • Public Company3.06%
  • Government Pension Fund0.20%
  • Family Office/Trust0.15%

Reported short interest has risen from 11.80% to 12.54% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +1,343,249 1.1%
Barclays Bank Plc Private Company 2026/Q3 +800,602 0.3%
UBS Asset Management Mutual Fund 2026/Q3 +795,914 0.5%
Morgan Stanley Public Company 2026/Q3 +662,094 1.2%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +662,094 1.2%
Jane Street Group, LLC Private Company 2026/Q3 +659,340 0.2%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +609,316 0.7%
Victory Capital Management Inc. Mutual Fund 2026/Q3 +514,097 0.2%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +402,901 0.1%
Calamos Investments LLC Mutual Fund 2026/Q3 +307,363 0.1%
Homestead Advisers Corp. Mutual Fund 2026/Q3 +263,900 0.1%
Sierra Summit Advisors LLC Family Office/Trust 2026/Q3 +202,450 0.1%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +199,118 0.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +444,189 0.1%
Diametric Capital, LP Hedge Fund 2026/Q3 +2,468,138 2.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
22 Sep 2026 Harry Thomasian Chief Financial Officer Derivative Exercise and Retained +53,665 $4.72 311,914
25 Aug 2026 Jeffrey Kindler Independent Director Open Market Disposition -185,000 $7.44 17,100
24 Aug 2026 Rutul Shah Chief Operating Officer Intent to Sell (Form 144) -15,342 $7.50 –
24 Aug 2026 Phil Tennant Chief Commercial Officer Derivative Exercise and Sale -79,166 $7.50 141,992
24 Aug 2026 Rutul Shah Chief Operating Officer Derivative Exercise and Sale -50,000 $7.50 468,865
22 Aug 2026 Harry Thomasian Chief Financial Officer Derivative Exercise and Sale -3,577 $7.20 258,249
22 Aug 2026 Harry Thomasian Chief Financial Officer Derivative Exercise and Retained +3,714 – 258,249
22 Aug 2026 Donald Lehr Chief Legal Officer Derivative Exercise and Sale -2,488 $7.20 758,181
22 Aug 2026 Donald Lehr Chief Legal Officer Derivative Exercise and Retained +2,720 – 758,181
22 Aug 2026 Helen Sabzevari Chief Executive Officer Derivative Exercise and Sale -10,184 $7.20 3,779,521
22 Aug 2026 Helen Sabzevari Chief Executive Officer Derivative Exercise and Retained +10,649 – 3,779,521
22 Aug 2026 Rutul Shah Chief Operating Officer Sale to Issuer -3,647 $7.20 468,865
22 Aug 2026 Rutul Shah Chief Operating Officer Derivative Exercise and Retained +7,500 – 468,865
22 Aug 2026 Phil Tennant Chief Commercial Officer Sale to Issuer -2,585 $7.20 141,992
22 Aug 2026 Phil Tennant Chief Commercial Officer Derivative Exercise and Retained +5,208 – 141,992
20 Aug 2026 Nancy Agee Independent Director Open Market Acquisition +3,411 $7.23 309,187
20 Aug 2026 Rutul Shah Chief Operating Officer Intent to Sell (Form 144) -34,658 $7.50 –
5 Aug 2026 Rutul Shah Chief Operating Officer Automatic Disposition -32,739 $6.86 465,012
2 Aug 2026 Rutul Shah Chief Operating Officer Derivative Exercise and Sale -33,772 $6.50 497,751
30 Jul 2026 Harry Thomasian Chief Financial Officer Automatic Disposition -100,000 $6.06 254,535

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 44,908,434 12.5% 8.6
15 Oct 2026 46,390,144 13.0% 10.2
30 Sep 2026 47,547,517 13.3% 7.4
15 Sep 2026 42,278,237 11.8% 16.3
31 Aug 2026 42,180,337 11.8% 7.9
14 Aug 2026 42,240,157 11.8% 5.9

Discussion

No comments yet — be the first to weigh in on PGEN.

Sign in to join the discussion.

Scroll to Top